Dinutuximab Intravenous and Hyate:C
Determining the interaction of Dinutuximab Intravenous and Hyate:C and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dinutuximab
Brand name: Unituxin
Synonyms: Dinutuximab
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dinutuximab Intravenous-Hybrisil
- Dinutuximab Intravenous-Hycamtin
- Dinutuximab Intravenous-Hycamtin (Topotecan Capsules)
- Dinutuximab Intravenous-Hycamtin (Topotecan Injection)
- Dinutuximab Intravenous-Hycamtin Capsules
- Dinutuximab Intravenous-Hycamtin Intravenous
- Hyate:C-Diocto
- Hyate:C-Diotame
- Hyate:C-Diovan
- Hyate:C-Diovan (Valsartan Capsules)
- Hyate:C-Diovan (Valsartan Tablets)
- Hyate:C-Diovan HCT